Tag: travel

Posts with tag: travel

Latest Posts

Coca-Cola Earnings: Q4 Revenue, EPS, and What to Watch

PepsiCo and Coca-Cola earnings: Here's what Wall Street expects as Coke gains ground on its rival ahead of Q4 report

Coca-Cola Earnings Preview: Street Expects Strong Quarter, 2025 Guidance

Coca-Cola (KO) is expected to beat earnings estimates in its Q4 2022 report, driven by strong demand and a favorable pricing environment. Analysts forecast a 6.71% price/mix increase, partially offset by a slight decline in unit case volume.

Musk's Crusade Against the Federal Reserve

Billionaire Elon Musk calls for increased transparency and accountability of the Federal Reserve, suggesting a full audit and possibly appointing Ron Paul as chair.

US Stocks Rise on Monday as Investors Look Past Trump's Tariff Threats

US stocks rebounded Monday as investors looked beyond President Trump's latest tariff threats, including new levies on steel and aluminum imports. The Dow Jones Industrial Average added nearly 0.4%, while the S&P 500 and Nasdaq Composite rose approximately 0.6% and 1%, respectively, as shares of AI chip giant Nvidia surged 3% along with other tech stocks.

Elon Musk's $97.4 Billion Offer For OpenAI: The Battle for AI Supremacy

Elon Musk's $97.4 billion offer to buy OpenAI, the nonprofit that runs ChatGPT, was rejected by CEO Sam Altman. Altman countered with an offer to buy Twitter for $9.74 billion.

Lattice Semiconductor (LSCC): Q4 Revenue in Line, Stock Jumps on Guidance, Margin Pressure

Lattice Semiconductor's Q4 CY2024 earnings met revenue expectations but missed on EPS. Revenue declined 31.2% YoY to $117.4 million, while adjusted EPS was $0.15, missing estimates by 20.7%. Despite these results, the company anticipates revenue growth of 1.4% in Q1 CY2025 and a higher adjusted EPS guidance. Analysts recommend further research before investing.

PetMed Express Reports Q3 Loss

PetMed Express reports a loss of $707,000 in its fiscal third quarter

Vertex Pharmaceuticals Q4 Earnings Top Estimates: Should You Buy VRTX?

Vertex Pharmaceuticals (VRTX) Q4 results beat revenue estimates, rising 15.7% YoY to $2.91B. Non-GAAP EPS of $3.98 missed by 1%. Full-year revenue guidance at $11.88B aligns with estimates, implying 7.8% growth. Read our analysis to determine if now is the time to buy VRTX.

SPS Commerce Tops Q4 Estimates, Posts Earnings of 89 Cents Per Share

SPS Commerce Q4 earnings beat expectations, with EPS of $0.89 and revenue of $170.9 million. For the full year, the company reported profit of $77.1 million, or $2.04 per share, on revenue of $637.8 million.

Simpson Manufacturing Reports Fourth-Quarter Profit

Simpson Manufacturing Co. reports $55.5 million in fourth-quarter profit and annual revenue of $2.23 billion.